# Performance Under SGLT-2-Inhibitors in Humans

> **NCT03422263** · — · COMPLETED · sponsor: **Berner Klinik Montana** · enrollment: 450 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03422263
- **Lead sponsor:** Berner Klinik Montana
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03422263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03422263, "Performance Under SGLT-2-Inhibitors in Humans". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03422263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*